Company intelligence / Profile preview
Cosette Pharmaceuticals
- Ownership
- Private
- Employees
- ~830
- Development stage
- Commercial
Overview
Cosette Pharmaceuticals has a rapidly expanding portfolio of over 80 generic and branded drugs across women’s health, dermatology, cardiology/cardiovascular disease and pediatrics. The company recently transformed into a leader in women’s health and dermatology through its acquisition of Mayne Pharma. Its pipeline includes both internally developed generics/brands as well as products gained via acquisition or partnership. Recent launches include generic metronidazole gel for rosacea/acne and dapsone gel for acne vulgaris; the company also markets Vyleesi® for hypoactive sexual desire disorder in premenopausal women
- Therapeutic areas
- Metabolic DisordersOtherDermatologyCardiovascularWomen's Health
- Modalities
- Small moleculessynthetic peptidespolymers
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Cosette Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cosette Pharmaceuticals.